This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sugimoto, T. Articles by Nakase, S. Search for Related Content PubMed PubMed Citation Articles by Sugimoto, T. Articles by Nakase, S. Social Bookmarking                         What's this?

Electrophysiologic Effects of Diltiazem, a Calcium Antagonist, in Patients With Impaired Sinus or Atrioventricular Node Function

From the Department of Internal Medicine, Toyama Medical and Pharmaceutical University, and Toyama Prefectural Central Hospital, Toyama, Japan

Tadao Ishikawa

From the Department of Internal Medicine, Toyama Medical and Pharmaceutical University, and Toyama Prefectural Central Hospital, Toyama, Japan

Kensuke Kaseno

From the Department of Internal Medicine, Toyama Medical and Pharmaceutical University, and Toyama Prefectural Central Hospital, Toyama, Japan

Shin'ichi Nakase

From the Department of Internal Medicine, Toyama Medical and Pharmaceutical University, and Toyama Prefectural Central Hospital, Toyama, Japan

The electrophysiologic effects of diltiazem, a calcium antagonistic agent, were studied in 30 subjects with various degrees of sinus or AV node dysfunc tion. After diltiazem was administered, sinus activity was not depressed in con trol subjects, whereas marked inhibition was observed in some of the patients with sick sinus syndrome. Ventricular automaticity was little affected by this drug. The AV conduction system was significantly depressed, and there was no difference in degree between controls and AV block patients. The depression of the AV conduction system became more marked as the basic atrial cycle length was shortened. The drug had no apparent effects on atrial refractoriness, atrial echo zone, or the accessory pathway system.

Conclusively, diltiazem affects mainly sinus and AV conduction systems. Its effect on the sinus node may provide a hazardous problem in patients with the sick sinus sysdrome patients, while its effect on the AV node will have thera peutic value in patients with AV nodal re-entrant arrhythmias.

Angiology, Vol. 31, No. 10, 700-709 (1980)
DOI: 10.1177/000331978003101006


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. N. Singh Pharmacological Basis for the Therapeutic Applications of Slow-Channel Blocking Drugs Angiology, August 1, 1982; 33(8): 492 - 515. [PDF]